Rosetta Genomics Ltd (ROSGQ)
0.00
USD |
OTCM |
May 24, 16:00
Rosetta Genomics Shareholders Equity (Quarterly): 1.099M for June 30, 2017
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2017 | 1.099M |
| December 31, 2016 | 4.417M |
| September 30, 2016 | 8.921M |
| June 30, 2016 | 12.65M |
| March 31, 2016 | 15.81M |
| December 31, 2015 | 19.62M |
| September 30, 2015 | 17.18M |
| June 30, 2015 | 19.82M |
| December 31, 2014 | 15.06M |
| June 30, 2014 | 19.88M |
| December 31, 2013 | 23.63M |
| June 30, 2013 | 27.94M |
| December 31, 2012 | 30.90M |
| June 30, 2012 | 3.717M |
| June 30, 2011 | 3.439M |
| March 31, 2011 | 5.736M |
| December 31, 2010 | -1.43M |
| September 30, 2010 | 0.726M |
| Date | Value |
|---|---|
| June 30, 2010 | 4.864M |
| March 31, 2010 | 9.424M |
| December 31, 2009 | 6.842M |
| September 30, 2009 | 10.28M |
| June 30, 2009 | 13.33M |
| March 31, 2009 | 12.76M |
| December 31, 2008 | 16.10M |
| September 30, 2008 | 14.85M |
| June 30, 2008 | 16.46M |
| March 31, 2008 | 19.89M |
| December 31, 2007 | 23.60M |
| September 30, 2007 | 31.48M |
| June 30, 2007 | 33.36M |
| March 31, 2007 | 35.33M |
| December 31, 2006 | 11.10M |
| December 31, 2005 | -2.323M |
| December 31, 2004 | 1.291M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Compugen Ltd | 59.68M |
| Pluri Inc | -0.356M |
| BioLine Rx Ltd | 13.22M |
| Can Fite Biofarma Ltd | 6.243M |
| BiomX Inc | -9.544M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.207M |
| Total Liabilities (Quarterly) | 5.108M |